DOJ official notes unusual aspects of Bayer/Monsanto decision

As the merger between Bayer and Monsanto awaits sign-off by a judge, a senior Department of Justice official has highlighted “unique” provisions in the proposed consent decree – including the lack of a contingency plan for an alternative divestiture buyer.

Get unlimited access to all Global Competition Review content